<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial treatment of multiple myeloma in resource-limited settings</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial treatment of multiple myeloma in resource-limited settings</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial treatment of multiple myeloma in resource-limited settings</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd"><p>In MM, we define resource-limited settings as those areas with limited access to thalidomide analogs, proteasome inhibitors, monoclonal antibodies, and other novel agents. There is no standard of care and different experts use different regimens.</p>
In addition to therapy directed at the malignant clone, the management of most patients with MM includes preventative measures to reduce the incidence of skeletal events, kidney damage, infections, and thrombosis.</div><div class="graphic_footnotes"><p>MM: multiple myeloma; HCT: hematopoietic cell transplantation; VCd: bortezomib, cyclophosphamide, and dexamethasone; VTd: bortezomib, thalidomide, and dexamethasone; CTd: cyclophosphamide, thalidomide, and dexamethasone; MPT: melphalan, prednisone, and thalidomide; VRd: bortezomib, lenalidomide, dexamethasone.</p>
<p>* The number of cycles used depends on how quickly logistical arrangements can be made to proceed with stem cell collection and HCT.</p>
<p>¶ If the patient has access to lenalidomide, VRd is preferred instead of VCd or VTd. Those who undergo HCT are offered post-HCT lenalidomide maintenance. Those who do not undergo HCT are offered 8 to 12 cycles of VRd followed by lenalidomide maintenance.</p>
<p>Δ While thalidomide maintenance prolongs remission, use is limited by toxicity, especially neurotoxicity.</p>
◊ The number of cycles used depends on how well they tolerate the regimen and the response to treatment. If the disease continues to respond and the patient is tolerating therapy, we will offer up to 12 cycles of initial therapy.</div><div id="graphicVersion">Graphic 139946 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
